Ken Griffin Emergent Bio Solutions Inc. Put Options Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $148,428 - $557,004	79,800 Added 131.03%	140,700 $959,000
Q1 2024 May 15, 2024	BUY	$1.5 - $3.41 $8,100 - $18,414	5,400 Added 9.73%	60,900 $154,000
Q4 2023 Feb 14, 2024	SELL	$1.82 - $3.16 $42,406 - $73,628	-23,300 Reduced 29.57%	55,500 $133,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $119,192 - $297,416	37,600 Added 91.26%	78,800 $267,000
Q2 2023 Aug 14, 2023	SELL	$7.35 - $13.21 $284,445 - $511,227	-38,700 Reduced 48.44%	41,200 $302,000
Q1 2023 May 15, 2023	BUY	$7.79 - $16.29 $517,256 - $1.08 Million	66,400 Added 491.85%	79,900 $827,000
Q4 2022 Feb 14, 2023	SELL	$11.0 - $21.45 $114,400 - $223,080	-10,400 Reduced 43.51%	13,500 $159,000
Q3 2022 Nov 14, 2022	BUY	$20.09 - $35.8 $98,441 - $175,420	4,900 Added 25.79%	23,900 $502,000

154

30.2M

137K

706K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $349M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.